Dr. Jonathan Gerber
Claim this profileUMass Memorial Medical Center
Studies Syndrome
Studies Myelodysplastic Syndrome
6 reported clinical trials
17 drugs studied
Affiliated Hospitals
Clinical Trials Jonathan Gerber is currently running
Onureg
for Cancer in Liver Failure
The purpose of this study is to evaluate the effect of moderate or severe liver impairment on the drug levels of oral azacitidine and the safety and tolerability of oral azacitidine in participants with myeloid malignancies.
Recruiting3 awards Phase 1
Luspatercept
for Myelodysplastic Syndrome
The purpose of this study is to evaluate the efficacy and safety of Luspatercept when administered at the maximum approved dose in low-risk Myelodysplastic Syndrome participants who require red blood cell transfusions.
Recruiting2 awards Phase 33 criteria
More about Jonathan Gerber
Clinical Trial Related1 year of experience running clinical trials · Led 6 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Jonathan Gerber has experience with
- Azacitidine
- Luspatercept
- MBG453
- Decitabine
- INQOVI (oral Decitabine)
- Asciminib
Breakdown of trials Jonathan Gerber has run
Myelodysplastic Syndrome
Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jonathan Gerber specialize in?
Jonathan Gerber focuses on Syndrome and Myelodysplastic Syndrome. In particular, much of their work with Syndrome has involved treating patients, or patients who are undergoing treatment.
Is Jonathan Gerber currently recruiting for clinical trials?
Yes, Jonathan Gerber is currently recruiting for 2 clinical trials in Worcester Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Jonathan Gerber has studied deeply?
Yes, Jonathan Gerber has studied treatments such as Azacitidine, Luspatercept, MBG453.
What is the best way to schedule an appointment with Jonathan Gerber?
Apply for one of the trials that Jonathan Gerber is conducting.
What is the office address of Jonathan Gerber?
The office of Jonathan Gerber is located at: UMass Memorial Medical Center, Worcester, Massachusetts 01655 United States. This is the address for their practice at the UMass Memorial Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.